Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

443 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytokine treatment of bacterial pneumonia.
Nelson S, Bagby GJ, Dale D. Nelson S, et al. Among authors: dale d. Semin Respir Infect. 2001 Mar;16(1):38-46. doi: 10.1053/srin.2001.22727. Semin Respir Infect. 2001. PMID: 11309711 Review.
A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.
Nelson S, Belknap SM, Carlson RW, Dale D, DeBoisblanc B, Farkas S, Fotheringham N, Ho H, Marrie T, Movahhed H, Root R, Wilson J. Nelson S, et al. Among authors: dale d. J Infect Dis. 1998 Oct;178(4):1075-80. doi: 10.1086/515694. J Infect Dis. 1998. PMID: 9806037 Clinical Trial.
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.
Dale DC, Crawford J, Klippel Z, Reiner M, Osslund T, Fan E, Morrow PK, Allcott K, Lyman GH. Dale DC, et al. Support Care Cancer. 2018 Jan;26(1):7-20. doi: 10.1007/s00520-017-3854-x. Epub 2017 Sep 22. Support Care Cancer. 2018. PMID: 28939926 Free PMC article. Review.
Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo.
Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Gaviria JM, et al. Among authors: dale dc. J Infect Dis. 1999 May;179(5):1301-4. doi: 10.1086/314728. J Infect Dis. 1999. PMID: 10191242 Clinical Trial.
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK, Dale DC. Root RK, et al. Among authors: dale dc. J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857. J Infect Dis. 1999. PMID: 10081506 Review.
Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Gaviria JM, et al. Among authors: dale dc. J Infect Dis. 1999 Apr;179(4):1038-41. doi: 10.1086/314679. J Infect Dis. 1999. PMID: 10068606
Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens.
Liles WC, Huang JE, van Burik JA, Bowden RA, Dale DC. Liles WC, et al. Among authors: dale dc. J Infect Dis. 1997 Apr;175(4):1012-5. doi: 10.1086/513961. J Infect Dis. 1997. PMID: 9086172
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.
Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P, et al. Dale DC, et al. Blood. 1993 May 15;81(10):2496-502. Blood. 1993. PMID: 8490166 Free PMC article. Clinical Trial.
Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases.
Dale DC. Dale DC. Clin Infect Dis. 1994 Feb;18 Suppl 2:S180-8. doi: 10.1093/clinids/18.supplement_2.s180. Clin Infect Dis. 1994. PMID: 8148463 Review.
443 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback